We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
National spending on prescription drugs ballooned five-fold in 2014, with much of it going toward specialty drugs, according to a new report from the Centers for Medicare & Medicaid Services. Read More
The UK’s pricing watchdog said it does not recommend reimbursement for Alexion’s Strensiq because it does not provide enough value for its high price. Read More
Drugmarkers are reporting a 20 percent improvement in securing their supply chains compared with a year ago, according to findings from a new report. Read More
A recent report suggests the advisory committees that the FDA relies upon to ensure medical products are safe and effective can be wildly inconsistent in their recommended approval rates. Read More
Real-world research offers the potential to better understand a medicine’s value in a clinical setting, but to fully harness its potential, drugmakers will need to restructure the way they think. Read More